The effect of reduced levels of circulating alpha-1 antitrypsin (AAT) on immune cells in alpha-1 antitrypsin deficient patients

被引：0
|
作者：
Lacey, N. [1 ]
McElvaney, O. J. [1 ]
White, M. M. [1 ]
Lee, M. Q. [1 ]
Hoo, M. C. S. [1 ]
McElvaney, N. G. [1 ]
Reeves, E. P. [1 ]
机构：
[1] Beaumont Hosp, Educ & Res Ctr, Dept Med, Irish Ctr Genet Lung Dis, Smurfit Bldg, Dublin 9, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2017年 / 186卷 / SUPPL 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
7.9
引用
收藏
页码：S424 / S425
页数：2
相关论文
共 50 条
  • [1] Evaluating the Systemic Effect of Reduced Levels of Circulating Alpha-1 Antitrypsin (AAT) on Circulating Immune Cells in Alpha-1 Antitrypsin Deficient Patients
    Lacey, N.
    McElvaney, O. J.
    White, M. M.
    McElvaney, N. G.
    Reeves, E. P.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S478 - S479
  • [2] Alpha-1 Antitrypsin Substitution for Extrapulmonary Conditions in Alpha-1 Antitrypsin Deficient Patients
    Baranovski, Boris M.
    Schuster, Ronen
    Nisim, Omer
    Brami, Ido
    Lior, Yotam
    Lewis, Eli C.
    [J]. CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2018, 5 (04): : 267 - 276
  • [3] Reduced levels of Circulating Alpha-1 Antitrypsin (AAT) Results in Increased Circulating Neutrophil Elastase and Activated Platelets in AAT Deficient Patients
    Lacey, N.
    White, M.
    O'Brien, M. E.
    Landers, S. A.
    McElvaney, N. G.
    Reeves, E. P.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S498 - S498
  • [4] Evaluation of AAT phenotyping in patients with low alpha-1 antitrypsin levels
    Moeez, Maqbool
    Carroll, Tomas P.
    Heeney, Ronan
    Hayes, Elaine
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 : S164 - S164
  • [5] Alpha-1 Antitrypsin Variability in COPD Patients with Normal Alpha-1 Antitrypsin Genotype
    Alarcon-Calderon, A.
    Campos, M. A.
    Urdaneta, G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [6] Alpha-1 antitrypsin (AAT) polymerization in alveolar macrophages of AAT deficient individuals and in smokers
    Bazzan, Erica
    Tine, Mariaenrica
    Benetti, Riccardo
    Miranda, Elena
    Biondini, Davide
    Turato, Graziella
    Sgambato, Manuel A.
    Rea, Federico
    Calabrese, Fiorella
    Baraldo, Simonetta
    Lomas, David A.
    Cosio, Manuel G.
    Saetta, Marina
    Rigobello, Chiara
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [7] THE LIMITATIONS OF SERUM ALPHA-1 ANTITRYPSIN LEVELS IN PATIENTS WITH CHRONIC LIVER DISEASE AND HETEROZYGOUS ALPHA-1 ANTITRYPSIN DEFICIENCY
    Mela, M.
    Smeeton, W.
    Alexander, G.
    [J]. GUT, 2011, 60
  • [8] Alpha-1 Antitrypsin Levels in Patients With Cerebral Aneurysms
    Kueppers, Friedrich
    Sultan, Farah
    Weaver, Michael
    Sanders, Christopher
    [J]. CHEST, 2015, 148 (04)
  • [9] Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?
    Modrykamien, Ariel
    Stoller, James K.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (16) : 2653 - 2661
  • [10] Liver cirrhosis and abnormally low serum levels of alpha-1 antitrypsin in the absence of alpha-1 antitrypsin deficiency
    Vyas, S
    Yuoh, G
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 806 - 806
12345